Rowland Thomas Andrew
SEC CIK 1507496 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANIP | ANI PHARMACEUTICALS INC | SVP, HEAD - ESTABLISHED BRANDS | 38.3K | — | $820.2K | 11 | 2024-11-15 | 2026-05-12 |
Most active insiders at ANIP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lalwani Nikhil | Pres, CEO, Dir | — | $5.05M |
| 2 | Walsh Patrick D | Dir | — | $2.32M |
| 3 | CAREY STEPHEN P. | SVP, CFO | — | $1.78M |
| 4 | Mutz Christopher | HEAD OF RARE DISEASE | — | $1.64M |
| 5 | Gassert Chad | SVP - CORP. DEV, STRATEGY | — | $1.31M |
| 6 | Davis Krista | SVP, Chief HR Off | — | $918.6K |
| 7 | Gutwerg Ori | SVP, GENERICS | — | $621.4K |
| 8 | Cook Meredith | SVP, GC, SEC | — | $453.9K |
| 9 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | — | $393.8K |
| 10 | HAUGHEY THOMAS | Dir | — | $161.8K |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-13 16:16 | 2026-05-12 | ANIP | ANI PHARMACEUTICALS INC | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | S - Sale | $79.21 | -459 | 38.3K | -1% | -$36.4K | |
| 2026-03-13 | 2026-03-11 | ANIP | ANI PHARMACEUTICALS INC | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | S - Sale | $74.91 | -4,772 | 38.7K | -11% | -$357.5K | |
| 2026-03-02 | 2026-02-26 | ANIP | ANI PHARMACEUTICALS INC | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | A - Grant | $77.15 | +6,021 | 44.1K | +16% | +$464.5K | |
| 2026-03-02 | 2026-02-28 | ANIP | ANI PHARMACEUTICALS INC | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F - Tax | $73.90 | -628 | 43.5K | -1% | -$46.4K | |
| M | 2026-02-17 | 2026-02-12+ | ANIP | ANI PHARMACEUTICALS INC | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F - Tax | $77.00 | -1,051 | 38.6K | -3% | -$80.9K |
| 2026-02-13 | 2026-02-11 | ANIP | ANI PHARMACEUTICALS INC | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F - Tax | $76.25 | -1,762 | 39.2K | -4% | -$134.4K | |
| 2025-08-14 | 2025-08-12 | ANIP | ANI PHARMACEUTICALS INC | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | S - Sale | $85.71 | -4,975 | 40.8K | -11% | -$426.4K | |
| 2025-03-04 | 2025-02-28 | ANIP | ANI PHARMACEUTICALS INC | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F - Tax | $61.89 | -627 | 45.5K | -1% | -$38.8K | |
| M | 2025-02-18 | 2025-02-12 | ANIP | ANI PHARMACEUTICALS INC | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | A - Grant | $0.00 | +13.1K | 41.5K | +46% | $0 |
| 2025-02-18 | 2025-02-14 | ANIP | ANI PHARMACEUTICALS INC | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F - Tax | $58.92 | -582 | 46.1K | -1% | -$34.3K | |
| 2024-11-18 | 2024-11-15 | ANIP | ANI PHARMACEUTICALS INC | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F - Tax | $56.58 | -867 | 33.2K | -3% | -$49.1K |
Purchase Sale Sale after option exercise All abbreviations